Nanophagix

NanoPhoria

This company develops an inhalable nano-drug delivery platform and therapeutics for patients with heart failure and other cardiovascular diseases.

Cyclarity

This biopharmaceutical company develops engineered cyclodextrin molecules to remove arterial plaque and treat age-related vascular diseases for patients with atherosclerosis and heart conditions.

Cardurion Pharmaceuticals

This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.

Elastrin

This biotechnology company develops nanoparticle therapies targeting damaged elastin to reverse tissue calcification for patients with cardiovascular and age-related diseases.

ScionxBio

This biotechnology company develops long-acting RNA medicines for pharmaceutical partners and patients with cardio-metabolic diseases.

Argonaute RNA

This biotechnology firm develops bispecific siRNA therapeutics for cardiometabolic diseases, serving pharmaceutical partners and research institutions engaged in advanced therapeutic research.

Staten Biotechnology

This company develops monoclonal antibody therapies for patients with dyslipidaemia to reduce cardiovascular risk and lower triglyceride levels.

Glympse Bio

This biotechnology firm develops tunable biosensor platforms and injectable nanoparticles for non-invasive disease monitoring and diagnostic testing for pharmaceutical companies and healthcare providers.